Omega Protein — Investor Presentation (December 2011)
24 slides from Omega Protein's investor presentation, Dec 5, 2011

Slide 1: Investor Presentation
Investor Presentation December 6, 2011 Exhibit 99.1

Slide 2: Forward Looking Statements
Forward Looking Statements The information presented herein may contain projections, predictions, estimates and other forward- looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Forward-looking statements will us

Slide 3: Presentation Overview
Presentation Overview Investment Highlights Favorable Supply Demand Outlook Operational Overview Growth Initiatives Business Divisions Review Financial Highlights

Slide 4: Investment Highlights
Investment Highlights Pure play on high quality protein ingredients and omega-3 fatty acids Benefitting from increasing demand for nutritional ingredients and limited supply of fish meal and fish oil Vertically integrated operations with significant barriers to entry Strong 2010 financial performanc

Slide 5: Growing Demand for Oil and Protein Around the World
Growing Demand for Oil and Protein Around the World Global Demand for Meat World Population Standards of Living Developing Countries* GDP per Capita (PPP) * As defined by the World Bank- 2010-2011 +37% +27% +17% Beef Pork Poultry Other Global Demand for Seafood 5.60 5.80 6.00 6.20 6.40 6.60 6.80 7.0

Slide 6: World Supply/Demand Imbalance
World Supply/Demand Imbalance Global Fish Meal Production Global Fish Oil Production Source: IFFO, 2010 6,240 6,201 5,292 6,226 5,868 5,092 5,052 4,972 4,775 4,134 1,000 2,000 3,000 4,000 5,000 6,000 7,000 1,132 1,006 1,129 1,061 1,056 1,031 1,000 1,200

Slide 7: Our Business Fuels Healthy Living
Our Business Fuels Healthy Living Omega Protein Corporation Human Nutrition Ingredients Animal Nutrition Ingredients Plant Nutrition Ingredients Nutraceuticals Functional Foods Aquaculture Feed Pet Food Livestock Feed Organic Fruits and Vegetables

Slide 8: Vertically Integrated: From Catch to Market
Vertically Integrated: From Catch to Market A sustainable fishery 49 vessels and 34 spotter planes 4 meal and oil processing plants Fish oil refinery and concentrating capability Sales and distribution network into top manufacturers

Slide 9: Organic Growth and Acquisitions: Growth Initiatives
Organic Growth Acquisitions Growth Initiatives Focus on research and development enhance production improve health benefits of end products develop novel new products Leverage customer relationships Allocate funds based on return on capital Additional product lines Increase presence in human nutriti

Slide 10: Animal Nutrition: Market is Growing
Animal Nutrition: Market is Growing Global Swine Production by Volume Global Aquaculture Production by Volume Global Pet food Market by Retail Sales 20,000 40,000 60,000 80,000 $44 $46 $48 $50 $52 $54 $56 $58 $60 30,000 60,000 90,000 120,000 Source: Aquaculture- FAO, 2011. http://www.fao.org/figis/s

Slide 11: Nutraceutical Ingredients Human Nutrition: Greatest Growth Potential
Nutraceutical Ingredients Human Nutrition: Greatest Growth Potential • Diverse product set of nutritional ingredients • Supply to the dietary supplement and functional food markets • Sales today represent a fraction of the market Source: “Global Nutrition Industry.” Nutrition Business Journal. March

Slide 12: Human Nutrition: Booming Supplement Market
Human Nutrition: Booming Supplement Market Source: “Global Omega-3 Industry Report.” Frost & Sullivan. September 2009.; “Top Supplements”. Consumer Lab.com. Survey, End Use Applications of EPA and DHA Oils (Metric Tons) Global Omega-3 Dietary Supplement Sales U.S. Omega-3 Dietary Supplement Sales $0

Slide 13: Human Nutrition: Acquisitive Growth (Cyvex)
Human Nutrition: Acquisitive Growth Background Transaction Rationale Founded in 1984 Located in Irvine, California Selling focus: health and well-being Strong customer relationships in the dietary supplements industry Focused on high-value, higher margin products Increase offering to the in human nu

Slide 14: Human Nutrition: Acquisitive Growth (InCon)
Human Nutrition: Acquisitive Growth Transaction Rationale Background Privately held company founded in 1993 Located near Chicago Strong technology base in molecular distillation and purification of nutritional compounds Existing producer of high purity omega-3’s Customer base includes numerous Fortu

Slide 15: Value Chain - Fish Oil for Human Nutrition
Value Chain-Fish Oil for Human Nutrition Vertical integration allows Omega Protein to capture additional value and further differentiate our fish oil Refine Process Harvest Market & Sell (Cyvex) Retail Concen- trate (InCon)

Slide 16: Plant Nutrition: Niche Opportunity
Plant Nutrition: Niche Opportunity OmegaGrow® Organic fertilizer produces healthier, faster growing plants OmegaGrow® Plus Provides the same benefits as OmegaGrow ® but with 25% oil to enhance plant health and fortification Seacide® Currently in process of bio-pesticide registration Nutritive Produc

Slide 17: R&D Initiatives Support Growth
R&D Initiatives Support Growth Comprehensive In-House Research and Development Effort Omega Protein Technology and Innovation Center Supports Process Innovation Enhances Menhaden Utilization Provides for Novel Product Development Benefits from Partnerships and Contracts with Universities - Analytica

Slide 18: Global Distribution Network
Global Distribution Network 2010 exports= over 50% of sales Source: Omega Protein Canada = 8.0% U.S. = 49.5% Latin America = 6.8% Europe = 11.7% Asia = 24.0% Optimize International Sales Maximize Pricing Enhance Margins

Slide 19: SMART ae) GD Tee
SMART ae) GD Tee #: Nestlé PURINA ————— Unleash Your Potential HH |, AShaklee

Slide 20: Income Statement Financial Highlights
Income Statement Financial Highlights $21 $40 $37 $8 $45 $140 $157 $177 $165 $168 $23 $35 $43 $8 $49 Gross Margin 2006-2010 (Million U.S. Dollars) Revenue 2006-2010 (Million U.S. Dollars) EBITDA 2006-2010 (Million U.S. Dollars) * 15% 26% 21% 5% 27% 0% 10% 20% 30% $0 $20 $40 $60 EBITDA EBITDA Margin

Slide 21: Balance Sheet Highlights
Balance Sheet Highlights $8 $19 $14 $2 $20 $75 $65 $61 $28 $35 Cash Balance (Million U.S. Dollars) Debt Balance (Million U.S. Dollars) $0 $5 $10 $15 $20 $25 3.6X 1.6X 1.7X 3.0X 0.8X 0.00 1.00 2.00 3.00 4.00 $0 $20 $40 $60 $80 Debt Debt/EBITDA Source: Omega Protein

Slide 22: Investment Summary
Investment Summary 1. Compelling fundamentals support increased demand for high quality oil and protein 2. Vertically integrated operations from catch to distribution 3. Opportunities for organic growth through new product development 4. Focus on acquisitions to expand product offerings and enter ne

Slide 23: Appendix I
Appendix I 2006 2007 2008 2009 2010 Net Income (loss) (6) Reconciling items: Interest expense Income tax provision (benefit) (3) Depreciation and amortization Debt refinancing costs - - - - Adjusted EBITDA The following table provides a reconciliation of Adjusted EBITDA*, a non-GAAP (Generally Accep

Slide 24: Appendix I
Appendix I *Adjusted EBITDA represents net income before interest expense, income tax, depreciation and amortization and debt financing costs. The Company has reported Adjusted EBITDA because it believes Adjusted EBITDA is a measure commonly reported and widely used by investors as an indicator of a
Source: SEC EDGAR · 8-K filed Dec 5, 2011
More decks from Omega Protein Corp
Investor Presentation (May 2017)27 slides · May 17, 2017
Investor Presentation (January 2017)27 slides · Jan 11, 2017
Proxy Contest (June 2016)48 slides · Jun 8, 2016
Proxy Contest (June 2016)36 slides · Jun 7, 2016
Investor Presentation (May 2016)29 slides · May 18, 2016
Investor Presentation (September 2015)25 slides · Sep 17, 2015